Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP).
Zufferey A, Kapur R, Semple JW. · 2017
Read Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP). by Zufferey A, Kapur R, Semple JW. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5332920.txt.
Description
Anne Zufferey, Rick Kapur, and John W. Semple reviewed a platelet disease in the Journal of Clinical Medicine in 2017. In immune thrombocytopenia, the body's own defenses drive blood platelet counts low. Low platelets raise the risk of bleeding. The disease can strike adults and children of both sexes, though its roots may differ by age.
The review sorts the attack paths. Antibodies mark platelets for ruin, killer T cells destroy them directly, and the bone marrow cells that make platelets also falter. Off-balance T cells and signal chemicals add to the mix. Care aims not at normal counts but at counts safe enough to stop bleeding. First care blocks antibody making and platelet loss. Later steps calm the immune system, remove the spleen, or push the marrow to make more platelets.
Catalog record
| CREATOR | Zufferey A, Kapur R, Semple JW. |
|---|---|
| YEAR | 2017 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 85 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |